U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
Solventum announced that U.S. News & World Report will expand its use of Solventum's AM-PPCs software in analyzing the 2024-2025 Best Hospitals rankings. The software will now be used in the Ear, Nose & Throat specialty ranking, the Prostate Cancer Surgery rating, and the new Gynecological Cancer Surgery rating.
The AM-PPCs software helps identify potentially preventable complications in outpatient settings. Preliminary analysis shows complication rates can be as high as 13% for certain procedures, affecting patient safety and satisfaction. This expansion aims to improve procedural safety and quality improvement.
- Expansion of AM-PPCs software use in high-visibility rankings like U.S. News & World Report's Best Hospitals.
- Potential for increased revenue through new applications of the software in multiple medical specialties.
- Preliminary analysis indicates the software's effectiveness in identifying complications, which can improve healthcare quality.
- High complication rates (up to 13%) identified, indicating a need for significant improvements in outpatient care. Continuous improvements may be required to maintain credibility and effectiveness.
Insights
The expansion of Solventum's AM-PPCs software usage in U.S. News & World Report's hospital rankings has significant implications for the healthcare industry. By incorporating this software into the rankings, it emphasizes the increasing importance of outpatient procedural safety.
The software’s ability to identify potentially preventable complications is important for improving patient care. Because outpatient settings have become the primary locations for many surgeries, monitoring and reducing complications can save costs and enhance patient outcomes.
This development can push hospitals to invest more in quality improvement initiatives, as their rankings directly affect reputation and patient choice.
Retail investors should recognize that increased reliance on data-driven evaluation tools reflects a growing trend towards transparency and accountability in healthcare.
Understanding complex metrics like complication rates and patient safety benchmarks is essential. These metrics provide a clearer picture of hospital performance beyond traditional outcomes, capturing elements of patient experience and long-term health impacts.
From a financial perspective, the expanded use of Solventum’s AM-PPCs software by a prestigious publication like U.S. News & World Report could positively impact Solventum's market position. Leveraging their technology in highly visible hospital rankings highlights Solventum's value proposition to healthcare providers and payers.
This increased visibility may drive further adoption of their software, leading to revenue growth. The integration into multiple specialty areas (Ear, Nose & Throat, Prostate Cancer Surgery and Gynecological Cancer Surgery) can diversify their client base and reduce dependency on any single service line.
Moreover, as hospitals strive to improve their rankings, they may be more inclined to invest in Solventum’s solutions, thus broadening Solventum's market reach and fortifying its competitive advantage. Investors should monitor subsequent earnings reports for revenue and client growth metrics to assess the long-term financial impact.
"We are excited to support
Developed to address patient safety and quality oversight for procedures performed in hospital outpatient departments or ambulatory surgery centers. It uses sophisticated grouping logic, and enables care providers, government entities, patient safety organizations and payers to identify and analyze potential complications in outpatient settings by specific procedures, service lines, providers and facilities within coding solutions and business intelligence systems. National benchmarks are also included.
Preliminary Solventum analysis of more than 23 million at-risk ambulatory procedures indicates that complication rates may be as high as
"We look forward to our continued work with Solventum to support promoting improved outpatient procedural safety. Although not all complications are preventable, excessive complications can be reduced if they are clearly identified and addressed," said Ben Harder, U.S. News & World Report managing editor and chief of health analysis. "Use of AM-PPCs were further extended this year to inform the Ear, Nose & Throat specialty ranking, as well as the Prostate Cancer Surgery rating and Gynecological Cancer Surgery procedure rating which will help us continue to build on our foundation of patient outcomes measurement in our Best Hospitals rankings."
1Analysis conducted using 3M AM-PPC Methodology and 2019-2022 CMS SAF files representing all Hospital Fee For Service (FFS) claims.
About Solventum
At Solventum (NYSE: SOLV), we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.
About U.S. News & World Report
View original content to download multimedia:https://www.prnewswire.com/news-releases/us-news--world-report-expands-use-of-solventums-ambulatory-potentially-preventable-complications-grouping-software-for-use-in-its-2024-2025-best-hospitals-rankings-302183482.html
SOURCE Solventum
FAQ
What is Solventum's AM-PPCs software used for?
Why is U.S. News & World Report expanding the use of Solventum's AM-PPCs software?
How high can complication rates be according to Solventum's preliminary analysis?
What are the benefits of using AM-PPCs software in hospital rankings?
When was the expansion of Solventum's software use announced?
